Crystal Schiller
Overview
Explore the profile of Crystal Schiller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hynd M, Gibson K, Walsh M, Phillips R, Prim J, Eisenlohr-Moul T, et al.
J Affect Disord
. 2024 Nov;
371:253-260.
PMID: 39581384
The perimenopausal transition is marked by an increased risk for affective dysregulation and major depressive disorder (MDD), with hormone replacement therapy using estradiol (E2) showing promise for alleviating symptoms of...
2.
Prim J, Favorov O, Jeffrey J, Girdler S, Schiller C
Stud Health Technol Inform
. 2024 Jan;
310:1546-1547.
PMID: 38269738
Wearable devices offer a unique opportunity to provide real-time monitoring of affective switching (the mood transition into and out of dysregulated affective state), a critical window to detect and prevent...
3.
Andersen E, Prim J, Campbell A, Schiller C, Baresich K, Girdler S
Dev Psychopathol
. 2023 Aug;
:1-15.
PMID: 37529837
The pubertal transition is characterized by pronounced sex hormone fluctuation, refinement of affective neural circuitry, and an increased risk of depression in female adolescents. Sex hormones, including testosterone, exert modulatory...
4.
Kimmel M, Thippeswamy H, Kamperman A, Madhuri H, Putnam K, Schiller C, et al.
Front Glob Womens Health
. 2022 Dec;
3:996501.
PMID: 36479233
Purpose: Assess postpartum depression and psychotic symptoms from three continents. Methods: Compare numbers of women with depression and psychotic symptoms, mania with or without psychotic features, or transient non-affective psychosis...
5.
Lozza-Fiacco S, Gordon J, Andersen E, Kozik R, Neely O, Schiller C, et al.
Psychoneuroendocrinology
. 2022 Jul;
143:105851.
PMID: 35809362
Background: The menopausal transition (perimenopause) is associated with an increased risk of major depression, characterized by anxiety and anhedonia phenotypes. Greater estradiol (E2) variability predicts the development of perimenopausal depression,...
6.
Andersen E, Geiger P, Schiller C, Bluth K, Watkins L, Zhang Y, et al.
Psychosom Med
. 2020 Dec;
83(6):515-527.
PMID: 33259351
Objective: Early life abuse (ELAb) initiates pathophysiological cascades resulting in long-term maladaptive stress responsivity, hyperalgesia, and an increased risk of psychopathology. Mindfulness-based stress reduction (MBSR) is effective in modifying psychological...
7.
Kimmel M, Cox E, Schiller C, Gettes E, Meltzer-Brody S
Obstet Gynecol Clin North Am
. 2018 Aug;
45(3):419-440.
PMID: 30092919
This review provides information about medications used to treat perinatal depression, including guidance around when to use certain medications and when to consult a mental health provider. For each group...